Learn More About AscentX Medical
Latest News
-
The Global Stress Urinary Incontinence Devices Market to Surpass USD 1 Billion Mark by 2027, Assesses DelveInsight
Read more: The Global Stress Urinary Incontinence Devices Market to Surpass USD 1 Billion Mark by 2027, Assesses DelveInsightAs per DelveInsight analysis in the stress urinary incontinence devices market, the growing demand for stress urinary incontinence is predominantly attributed to the increasing prevalence of stress urinary incontinence amongst women across the globe. Another prominent factor is the rising incidence of diabetes mellitus, obesity, and Parkinson’s disease, acting as risk factors for the development…
-
A minimally invasive, outpatient treatment for Gastroesophageal Reflux Disease (GERD), resulting in permanent relief from both GERD symptoms and life-long drug dependency
Read more: A minimally invasive, outpatient treatment for Gastroesophageal Reflux Disease (GERD), resulting in permanent relief from both GERD symptoms and life-long drug dependencyNovel treatment could cure potentially dangerous condition for millions An estimated 20-30 million Europeans suffer from Gastroesophageal Reflux Disease every day. Symptoms include heartburn and regurgitation. At best uncomfortable and at worst a cause of oesophageal cancer, a novel treatment could bring relief to hundreds of millions worldwide. Many of us will have experienced heartburn,…
-
AscentX Medical Receives Coveted Grant From European Union (EU)
Read more: AscentX Medical Receives Coveted Grant From European Union (EU)The MedTech company was selected to receive funding in support of a first-to-market procedure to cure Gastroesophageal Reflux Disease (GERD) SAN DIEGO, Sept. 17, 2019 /PRNewswire/ — AscentX Medical, Inc., a U.S. medical technology company focused on the clinical development of globally-impactful least-invasive medical treatment procedures, has been selected for the SME Instrument grant (Phase I) in the…